Ebrotidine

DB21220ExperimentalSmall molecule

Ebrotidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Ebrotidine is a histamine- H2-receptor antagonist, cimetidine derivative. Ebrotidine has a monoisotopic...

Mechanism: Pharmacologically active on Histamine H2 receptor
Curator reviewed
Formula / weight: C₁₄H₁₇BrN₆O₂S₃ · 477.41 g/mol (avg)

Resolves to

Compound

UNIITMZ3IBW2OWCAS100981-43-9ChEMBLCHEMBL1742471ChEBI135774

Structure

InChIKeyZQHFZHPUZXNPMF-UHFFFAOYSA-NSMILESNC(=N)NC1=NC(CSCCN\C=N\S(=O)(=O)C2=CC=C(Br)C=C2)=CS1

Targets

P25021HRH2

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

558Drug interactionsStructured to mechanism, not free text

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ebrotidine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account